ArticleJACC. Case reports2026
Atypical Presentation of Mycotic Coronary Artery Aneurysm.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMycotic coronary artery aneurysms (MCAAs) are extremely rare, constituting only 3% of all coronary aneurysms. They most often occur because of infective endocarditis or coronary stents, in particular drug-eluting stents. CASE SUMMARY: We report an unusual presentation of an MCAA presenting as a mediastinal mass after percutaneous coronary intervention (PCI). DISCUSSION: MCAA is an unusual yet potentially fatal complication of PCI with diagnostic difficulty that requires multimodal imaging. Although resection and revascularization are the optimal therapy, covered stenting is an alternative for less invasive intervention. Prompt diagnosis and intervention are key to better outcomes. TAKE-HOME MESSAGES: Although PCI is routine, there is a risk of bacteremia and associated complications such as MCAA. Close attention, early detection, and treatment are important for optimal results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.